🇺🇸 Ethinyl estradiol and norgestimate in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anaphylactic Reaction — 1 report (10%)
  2. Autonomic Nervous System Imbalance — 1 report (10%)
  3. Chest Pain — 1 report (10%)
  4. Colitis Ischaemic — 1 report (10%)
  5. Cyst — 1 report (10%)
  6. Diabetes Mellitus — 1 report (10%)
  7. Diabetic Ketoacidosis — 1 report (10%)
  8. Dizziness — 1 report (10%)
  9. Drug Dispensing Error — 1 report (10%)
  10. Dry Mouth — 1 report (10%)

Source database →

Ethinyl estradiol and norgestimate in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Ethinyl estradiol and norgestimate approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Ethinyl estradiol and norgestimate in United States?

University of Vermont is the originator. The local marketing authorisation holder may differ — check the official source linked above.